On account of CD276 has just been identified as a potential biomarker in colon cancer recently and has not yet become part of routine clinical application, there is certain difficulty to establish a large database that integrate CD276 expression and H&E-stained images. This evidence concerns the gene CD276 and malignant colon neoplasm.